| scholarly article | Q13442814 |
| P50 | author | Elizabeth Barrett-Connor | Q37322423 |
| Joachim H. Ix | Q87220141 | ||
| P2093 | author name string | Christina L Wassel | |
| Gail A Laughlin | |||
| Lori B Daniels | |||
| Kevin Cummins | |||
| Jaclyn Bergstrom | |||
| P2860 | cites work | Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups | Q22250884 |
| Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study | Q24297939 | ||
| The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification | Q24679476 | ||
| Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group | Q28261623 | ||
| The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects | Q28290472 | ||
| Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity | Q28574789 | ||
| The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis | Q28581026 | ||
| Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study | Q31111874 | ||
| Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes | Q33602340 | ||
| The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. | Q34022484 | ||
| Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound | Q35372354 | ||
| Vascular calcification: mechanisms and clinical ramifications | Q35779458 | ||
| Vascular calcification and fetuin-A deficiency in chronic kidney disease | Q36812086 | ||
| Plasma fetuin-A levels and the risk of type 2 diabetes | Q36906385 | ||
| Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). | Q36914416 | ||
| Relation of serum fetuin-A levels to coronary artery calcium in African-American patients on chronic hemodialysis. | Q37073515 | ||
| Fetuin-A and incident diabetes mellitus in older persons | Q37426398 | ||
| Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke | Q40025535 | ||
| Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18-20, 1992 New Orleans, Louisiana | Q40829260 | ||
| Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene | Q42524230 | ||
| The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor | Q42602286 | ||
| The relationship between coronary calcification and the metabolic markers of osteopontin, fetuin-A, and visfatin | Q43216627 | ||
| Risk factors for cardiovascular calcifications in non-diabetic Caucasian haemodialysis patients | Q43880716 | ||
| The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex | Q44391290 | ||
| Alcohol consumption and carotid atherosclerosis in older adults: the Cardiovascular Health Study | Q44620782 | ||
| Hormone therapy and coronary artery calcification in asymptomatic postmenopausal women: the Rancho Bernardo Study | Q45236867 | ||
| Plaque morphology in sudden coronary death. | Q50884540 | ||
| Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction. | Q50933676 | ||
| Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass. | Q51488638 | ||
| Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
| Vascular calcification in maintenance hemodialysis patients. | Q51749047 | ||
| Quantification of coronary artery calcium using ultrafast computed tomography. | Q52867038 | ||
| Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients. | Q53339264 | ||
| Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. | Q53455976 | ||
| Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index? | Q54397335 | ||
| KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. | Q55043049 | ||
| Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin | Q59319205 | ||
| Association of serum fetuin-A levels with mortality in dialysis patients | Q59361751 | ||
| Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients | Q61569111 | ||
| High plasma fetuin-A is associated with increased carotid intima-media thickness in a middle-aged population | Q61862467 | ||
| Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. | Q64913104 | ||
| The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population | Q67276328 | ||
| The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group | Q67748287 | ||
| Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group | Q68022503 | ||
| Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects | Q72898743 | ||
| Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase | Q73836032 | ||
| The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis | Q81233454 | ||
| Fetuin-A is associated with calcified coronary artery disease | Q84144806 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 2372-2379 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study | |
| P478 | volume | 58 |
| Q34768588 | Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients |
| Q46430033 | Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes |
| Q37677412 | Circulating fetuin-A and risk of ischemic stroke in women |
| Q41101238 | Effects of Exercise Training and Weight Loss on Plasma Fetuin-A Levels and Insulin Sensitivity in Overweight Older Men. |
| Q36415206 | Evaluation of Arterial Stiffness in Patients with Behçet's Disease by Using Noninvasive Radiological Methods such as Intima-Media Thickness of the Carotid, Ankle-Brachial Pressure Index, Coronary Artery Calcium Scoring, and Their Relation to Serum F |
| Q39179707 | Fetuin-A and Risk of Diabetes Independent of Liver Fat Content: The Multi-Ethnic Study of Atherosclerosis |
| Q38028344 | Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus |
| Q35809242 | Fetuin-A is related to infarct size, left ventricular function and remodelling after acute STEMI. |
| Q33740776 | Fetuin-A, a new vascular biomarker of cognitive decline in older adults |
| Q37684531 | Glycomic analysis of high density lipoprotein shows a highly sialylated particle |
| Q36354555 | Kidney function and progression of coronary artery calcium in community-dwelling older adults (from the Rancho Bernardo Study) |
| Q48165741 | Multibiomarker analysis in patients with acute myocardial infarction |
| Q64259279 | Non-traditional risk factors for coronary calcification and its progression in patients with type 2 diabetes: The impact of postprandial glycemia and fetuin-A |
| Q36072533 | Relationship between Fetuin A, Vascular Calcification and Fracture Risk in Dialysis Patients |
| Q37266056 | Serum biomarkers reveal long-term cardiac injury in isoproterenol-treated African green monkeys |
| Q36942233 | Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo study |
| Q45750937 | Subclinical atherosclerosis and fetuin-A plasma levels in essential hypertensive patients. |
| Q35936268 | The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study |
| Q92714508 | The impact of the AHSG genetic polymorphism on the risk of ischemic stroke: a case-control study |
| Q35762933 | Usefulness of fetuin-A to predict risk for cardiovascular disease among patients with obstructive sleep apnea |
| Q36181627 | Which biomarkers are predictive specifically for cardiovascular or for non-cardiovascular mortality in men? Evidence from the Caerphilly Prospective Study (CaPS). |
Search more.